vimarsana.com

Page 87 - முக்கிய வார்த்தைகள் ஸ்டுடியோக்கள் ப்ல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biden s German shepherd Major involved in White House incident resulting in a minor injury

President Biden s Dogs Removed From The White House | AM 600 WMT

Biden s German Shepherds sent back to Delaware after biting incident with White House staffer

Biden s German Shepherds sent back to Delaware after biting incident with White House staffer and last updated 2021-03-09 14:34:41-05 President Joe Biden’s two dogs have been moved away from the White House after one of the dogs showed aggressive behavior to White House staff, according to a report first published by CNN. The Bidens have two German Shepherds — a 13-year-old named Champ and 3-year-old named Major. Reports indicate that it was Major who was involved in a “biting incident” with a “member of White House security.” White House press secretary Jen Psaki confirmed Tuesday that the dogs had been returned to Delaware following an incident where Major got aggressive with a White House staffer. Psaki said that the dogs were still getting acclimated to the White House and that Major was surprised by a new person.

Lupin unit partners Endoceutics to commercialise Intrarosa in Canada

Lupin Pharma, a subsidiary of the drug major, announced a partnership with Endoceutics, a women s health focused innovative Canadian biotech company, to commercialize Intrarosa in Canada. Intrarosa is Endoceutic s flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of Prasterone. Intrarosa was developed in Quebec City, Canada by Endoceutics and will be manufactured in their facilities in Mont Saint Hilaire, Canada. Intrarosa is indicated for postmenopausal vulvovaginal atrophy, it is a vaginal ovule containing 6.5 mg of Prasterone. It comes in blister packs of 28 ovules, with 7 reusable applicators. The recommended dose is one vaginal ovule inserted once a day at bedtime, using the provided applicator or fingers. It is estimated that over 50% of postmenopausal women suffer from the symptoms of vulvovaginal atrophy and that less than 10% of these women are treated with prescription medicines.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.